AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 247 filers reported holding AXSOME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $553,116 | -23.1% | 6,871 | -23.8% | 0.02% | -25.0% |
| Q1 2024 | $719,397 | +8.7% | 9,015 | +8.4% | 0.03% | 0.0% |
| Q4 2023 | $661,711 | +16.4% | 8,314 | +2.2% | 0.03% | -9.7% |
| Q3 2023 | $568,415 | -10.6% | 8,133 | -8.0% | 0.03% | -8.8% |
| Q2 2023 | $635,530 | -2.1% | 8,844 | -16.0% | 0.03% | -15.0% |
| Q1 2023 | $649,182 | +170.7% | 10,525 | +238.5% | 0.04% | +150.0% |
| Q4 2022 | $239,797 | +18.1% | 3,109 | +26.2% | 0.02% | +45.5% |
| Q2 2020 | $203,000 | -26.7% | 2,464 | -8.1% | 0.01% | -8.3% |
| Q4 2019 | $277,000 | – | 2,680 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |